Ranbaxy News
Most Popular Ranbaxy Story
Numbers hint that Pfizer's Lipitor strategy may work
The latest figures on Lipitor sales suggest that Pfizer's ($PFE) aggressive sales strategies might—just might—be working. As The Associated Press reports, new IMS Health numbers show Read more...
Latest Headlines
- February 7, 2012
- February 3, 2012
- January 30, 2012
- January 26, 2012
- January 19, 2012
- January 17, 2012
- January 13, 2012
- December 21, 2011
- December 20, 2011
- December 13, 2011
- December 8, 2011
- December 7, 2011
- December 2, 2011
- December 1, 2011
- November 30, 2011
- November 28, 2011
- November 17, 2011
- November 14, 2011
- November 11, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
